Weighing the Evidence: A Pharmacy Approach to Stroke Prevention in Obese Patients with NVAF

After graduating as valedictorian from Boston Latin School, Dr. Bhatt obtained his undergraduate science degree as a National Merit Scholar at MIT while also serving as a research associate at Harvard Medical School. He received his medical doctorate from Cornell University and a Master of Public Health with a concentration in clinical effectiveness from Harvard University. His internship and residency in internal medicine were at the Hospital of the University of Pennsylvania, and his cardiovascular training was at Cleveland Clinic. Dr. Bhatt completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention and served as Chief Interventional Fellow at Cleveland Clinic, where he spent several years as an interventional cardiologist and an Associate Professor of Medicine. Most recently he received the AHA’s Distinguished Scientist Award in 2019 in addition to numerous other honors. Dr. Bhatt has been listed in Best Doctors in America from 2005 to 2020.

Dr. Bhatt’s research interests include acute coronary syndromes, preventive cardiology, and advanced techniques in cardiac, cerebral, and peripheral intervention. He has authored or co-authored over 1500 publications and has been listed by the Web of Science Group as a Highly Cited Researcher from 2014 to 2019. He was the international PI for the CHARISMA and CRESCENDO trials and co-PI of the three CHAMPION trials. He served as chair of COGENT and co- PI of STAMPEDE. Additionally, Dr. Bhatt serves as chair for REDUCE- IT and SCORED. In 2018, REDUCE-IT was listed and named the top cardiology trial by NEJM. In 2014, he was listed in the AHA/ASA top ten advances in heart disease and stroke research (for STAMPEDE and SYMPLICITY HTN-3).He serves as Senior Associate Editor for News and Clinical Trials for ACC.org, Editor of the peer-reviewed Journal of Invasive Cardiology, as well as Editor of Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease and Atherothrombosis in Clinical Practice published by Oxford University Press. He also serves as Editor-in-Chief of the Harvard Heart Letter for patients.

Dr. Kido is currently a clinical assistant professor of clinical pharmacy at West Virginia University School (WVU) of Pharmacy. Dr. Kido graduated from University of Iowa College of Pharmacy and completed his PGY 1 pharmacy practice residency and PGY 2 cardiology pharmacy residency at University of Kentucky HealthCare. He also received his Master of Science Degree from Keio University and his Bachelor of Science Degree from Kyoritsu College of Pharmacy in Japan.

Dr. Kido is a cardiology clinical pharmacy specialist in the WVU outpatient heart failure clinic and on the WVU inpatient heart failure service. His areas of research interests include anticoagulation in morbidly obese populations and the optimization of sacubitril/valsartan in real-world settings. Dr. Kido has published multiple original research articles and review articles in peer-reviewed journals. Dr. Kido is an active member in the American College of Clinical Pharmacy and American Society of Health-System Pharmacist. He currently serves as a committee member for multiple national pharmacy associations.

Edith Nutescu, Pharm.D., MS CTS, FCCP, is the Michael Reese Endowed Professor of Cardiovascular Pharmacotherapy and Head of the Department of Pharmacy Practice at University of Illinois at Chicago (UIC) College of Pharmacy. She also serves as the Co- Director of the Personalized Medicine Program at the University of Illinois Hospital and Health Sciences System (UI – Health) and is Affiliate Faculty in the Center for Pharmacoepidemiology and Pharmacoeconomic Research and Center for Dissemination and Implementation Science. Dr. Nutescu received her Doctor of Pharmacy from the UIC College of Pharmacy and her Master in Clinical and Translational Science from the UIC School of Public Health. She completed Pharmacy Practice and Specialty Residency (Primary Care with Cardiology Emphasis) training at Advocate Health Care, Lutheran General Hospital and UIC.

Dr. Nutescu’s research interests focus on comparative effectiveness and safety of cardiovascular pharmacotherapy and thromboembolic diseases. She has authored over 180 scientific articles and her research has been continuously funded by the National Institutes of Health, National Heart Lung and Blood Institute, The Department of Health and Human Services, the Agency for Healthcare Research and Quality, and the National Center for Research Resources, among others. She is a recipient of the Ruth L. Kirchstein National Research Service Award and National Heart Lung and Blood Institute Clinical Research Career Development Award. She has lectured extensively, both nationally and internationally, on topics related to personalized medicine, thrombosis, cardiovascular diseases and stroke. Her book, “Anticoagulation Therapy: A Clinical Practice Guide,” is used nationally and internationally to guide clinical practice guidelines and the bedside management of patients on anticoagulation therapy.

Dr. Nutescu serves as Scientific Editor for the journal Pharmacotherapy and has served on the editorial board for the American Journal of Health-System Pharmacy and Annals of Pharmacotherapy. She is active in several professional organizations including the American College of Clinical Pharmacy, the American Heart Association, the International Society for Thrombosis and Haemostasis, Academy Health, the Anticoagulation Forum, and the National Blood Clot Alliance. She has served on the Board of Regents for the American College of Clinical Pharmacy, on the National Consumers League Senior Outpatient Medication Safety Coalition, and was the only pharmacist member to serve on the steering committee of the National Quality Forum and The Joint Commission that developed “National Consensus Standards for the Prevention and Care of Venous Thrombosis.” Dr. Nutescu has been recognized as a Fellow of the American College of Clinical Pharmacy. She has received the American Society of Health System Pharmacists Foundation Award for Excellence in Medication-Use Safety, the American College of Clinical Pharmacy’s Clinical Practice Award, the Russel R. Miller Award for her substantial contributions to the literature of clinical pharmacy, and the Therapeutics Frontiers Award for her outstanding contributions to pharmacotherapeutics in her field.